8-K

Company

Mereo BioPharma Group plc

Filed

May 14, 2025

Period of Report

May 13, 2025

Accession Number

0000950170-25-071485

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →